PIMA529916

Swine Influenza H1N1 NA (strain Swine Flu 2009) Recombinant Rabbit Monoclonal Antibody (001), Invitrogen™

Manufacturer: Thermo Scientific

Select a Size

Pack Size SKU Availability Price
Each of 1 PIMA529916-Each-of-1 In Stock ₹ 50,507.50

PIMA529916 - Each of 1

₹ 50,507.50

In Stock

Quantity

1

Base Price: ₹ 50,507.50

GST (18%): ₹ 9,091.35

Total Price: ₹ 59,598.85

Antigen

Swine Influenza H1N1 NA (strain Swine Flu 2009)

Classification

Recombinant Monoclonal

Concentration

1 mg/mL

Formulation

PBS with no preservative

Host Species

Rabbit

Purification Method

Protein A

Regulatory Status

RUO

Target Species

Virus

Product Type

Antibody

Isotype

IgG

Applications

ELISA, Western Blot

Clone

001

Conjugate

Unconjugated

Gene Alias

H1N1 HA; H1N1 hemagglutinin; influenza a; Influenza H1N1; swine H1N1

Immunogen

Recombinant H1N1 NA Protein

Quantity

100 μL

Primary or Secondary

Primary

Content And Storage

Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.

Form

Liquid

Related Products

Img

Thermo Scientific

PIPA520943

--

Img

Thermo Scientific

PIPA585691

--

Img

Thermo Scientific

PIPA5140109

--

Img

Thermo Scientific

PIPA566525

--

Img

Thermo Scientific

PIPA563213

--

Img

Thermo Scientific

PIMA528509

--

Img

Thermo Scientific

PIPA559857

--

Img

Thermo Scientific

PIPA566543

--

Description

  • This product is preservative free
  • It is recommended to add sodium azide to avoid contamination (final concentration 0.05%-0.1%)
  • Recombinant rabbit monoclonal antibodies are produced using in vitro expression systems
  • The expression systems are developed by cloning in the specific antibody DNA sequences from immunoreactive rabbits
  • Then, individual clones are screened to select the best candidates for production
  • The advantages of using recombinant rabbit monoclonal antibodies include: better specificity and sensitivity, lot-to-lot consistency, animal origin-free formulations, and broader immunoreactivity to diverse targets due to larger rabbit immune repertoire
  • This antibody has specificity for H1N1 (A/California/04/2009) NA
  • Influenza A virus is a major public health threat, killing more than 30, 000 people per year in the USA
  • In early 2009, a novel swine-origin influenza A (H1N1) virus was identified in specimens obtained from patients in Mexico and the United States
  • The virus spread quickly around the world and on June 11, 2009, the World Health Organization declared it a pandemic
  • Influenza A virus has one of sixteen possible Hemagglutinin (HA) surface proteins and one of nine possible Neuraminidase (NA) surface proteins
  • The Hemagglutinin protein facilitates viral attachment while Neuraminidase is involved in viral release
  • These proteins also elicit immune responses that prevent infection or independently reduce viral replication
  • The genetic make-up of this swine flu virus is unlike any other: it is an H1N1 strain that combines a triple assortment first identified in 1998 including human, swine, and avian influenza with two new pig H3N2 virus genes from Eurasia, themselves of recent human origin
  • The distinct antigenic properties of the new swine virus compared with seasonal influenza A (H1N1) virus suggest that human immunity against new swine influenza virus is limited, although the age distribution of reported cases suggests some degree of protection in older age groups.